Clinical trial Recruiting at 1 site Interventional Ages 18 to 100

tDCS to improve swallowing in Parkinson's disease

Official title: Clinical Efficacy and Mechanism of tDCS for Dysphagia in Patients With Parkinson's Disease

Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT07153692 · Data updated 2026-11-12

This study tests whether adding transcranial direct current stimulation (tDCS) to standard swallowing therapy helps people with Parkinson's disease who have dysphagia.

Quick facts

Study typeInterventional
Ages18 Years to 100 Years
SexAll
Enrollment58 (estimated)
SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine
Academic / other
Locations1 site (Hangzhou, Zhejiang)
StatusRecruiting
StartedJuly 17, 2025
Main results expectedDecember 31, 2029
Study endsMarch 31, 2030
Registry record updatedSeptember 4, 2025
Trial IDNCT07153692 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with Parkinson's disease or atypical parkinsonian syndromes (MSA or PSP) who have dysphagia confirmed by VFSS, intact cognition (MMSE >23), and the ability to consent and cooperate are appropriate candidates.

Probably not a fit

Patients whose swallowing problems are caused by other diseases, those with active pneumonia or severe cardiac/renal failure, metal implants, or significant cognitive impairment or inability to cooperate are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional study will assign people with Parkinson's-related dysphagia to real tDCS plus conventional dysphagia treatment or sham tDCS plus conventional treatment. Swallowing function will be measured at baseline, after the intervention, and at a 3-month follow-up using videofluoroscopic swallowing study (VFSS) and clinical swallowing scales. Brain function will be tracked with resting-state fMRI or functional near-infrared spectroscopy (fNIRS), using ALFF and functional connectivity analyses to map changes in networks and regions. The study will correlate imaging changes with swallowing recovery to explore the neurophysiological mechanism of tDCS.

Why it matters

Potential benefit: If successful, tDCS could improve swallowing safety and function in people with Parkinson's, reducing aspiration risk and improving nutrition and quality of life.

How similar studies have gone: tDCS has shown promising results for post-stroke dysphagia and small pilot studies in Parkinson's suggest potential benefit, but robust randomized trials specifically in PD-related dysphagia are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Meet the Chinese Diagnostic Criteria for Parkinson's Disease (2016) or MDS Diagnostic Criteria for Multiple System Atrophy or Progressive Supranuclear Palsy;
* VFSS examination indicates dysphagia;
* Mini-Mental State Examination (MMSE) score \>23;
* Willing to cooperate with the study and sign the informed consent form;

Exclusion Criteria:

* Comorbid with other diseases that cause dysphagia;
* Comorbid with pneumonia, or severe cardiac/renal insufficiency;
* Having metal implants in the body
* With cognitive impairment or inability to cooperate.

Where it's running

  • Second Affiliated Hospital of Zhejiang University School of Medicine
    Hangzhou, Zhejiang, China
    Recruiting

Study contacts

  • Principal investigator: Ping Wang — Second Affiliated Hospital of Zhejiang University School of Medicine
  • Study coordinator: Ping Wang, MS
  • Email: wangping6288@zju.edu.cn
  • Phone: 15158113194

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.